Neuberger Berman Group LLC Bridge Bio Pharma, Inc. Transaction History

Neuberger Berman Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $196,057 - $268,715	-4,183 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $194,384 - $267,419	4,183 New	4,183 $250,000
Q1 2021 May 13, 2021	SELL	$55.47 - $72.35 $226,484 - $295,405	-4,083 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$38.38 - $71.11 $92,764 - $171,872	-2,417 Reduced 37.18%	4,083 $284,000
Q4 2019 Feb 12, 2020	BUY	$17.96 - $46.63 $116,740 - $303,095	6,500 New	6,500 $228,000

284

170M

7.41M

2.61M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.76B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.